Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease
- PMID: 32200855
- DOI: 10.1016/j.kint.2019.12.005
Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease
Keywords: anemia; chronic kidney disease; erythropoietin.
Comment on
-
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.N Engl J Med. 2019 Sep 12;381(11):1001-1010. doi: 10.1056/NEJMoa1813599. Epub 2019 Jul 24. N Engl J Med. 2019. PMID: 31340089 Clinical Trial.
-
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.N Engl J Med. 2019 Sep 12;381(11):1011-1022. doi: 10.1056/NEJMoa1901713. Epub 2019 Jul 24. N Engl J Med. 2019. PMID: 31340116 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical